• (Add Comment)

Hibiotic N 600 mg/5 mI Powder for suspension preparation 80 ml

  • Treatment of infectious and inflammatory diseases caused by susceptible pathogens:
  • Upper respiratory tract and ENT infections (otitis media, sinusitis, tonsillitis).
  • Lower respiratory tract infections (acute and chronic bronchitis, pneumonia, lung abscess, pleural empyema).
  • Urinary tract and pelvic infections (pyelonephritis, cystitis, urethritis, prostatitis, endometritis, gonorrhea).
  • Skin and soft tissue infections (erysipelas, impetigo, abscesses, cellulitis, wound infections).
  • Bone and joint infections (osteomyelitis).
  • Surgical infection prophylaxis and post-operative wound infections.

Buy

Product quantities

• Sharm El Sheikh: In stock
• Hurghada: In stock
• El-Alamein: Running out
• Cairo: In stock
• El-Tor: Out of stock

Form of Release: Powder

Hibiotic N 600 mg/5 mI Powder for suspension preparation 80 ml

Composition:

Active Ingredients:
Each 5 mL of reconstituted suspension contains
Amoxicillin (as trihydrate) 600 mg and Clavulanic Acid (as potassium clavulanate) 42.9 mg.
Excipients:
Trisodium citrate, citric acid, aerosil 200 (colloidal silicon dioxide), avicel (microcrystalline cellulose), dimethicone, lemon flavor, sucrose.

Product Description:

  • Hibiotic N is a broad-spectrum antibacterial combination consisting of amoxicillin (a semi-synthetic penicillin) and clavulanic acid (a beta-lactamase inhibitor).
  • Amoxicillin destroys bacteria by inhibiting bacterial cell wall synthesis.
    Clavulanic acid protects amoxicillin from degradation by beta-lactamase enzymes produced by resistant bacteria, thereby extending the antibacterial spectrum.
  • It is active against a wide range of Gram-positive and Gram-negative aerobic and anaerobic bacteria (including Staphylococcus, Streptococcus, Haemophilus influenzae, Streptococcus pneumoniae, Escherichia coli, and Klebsiella species).

Indications for Use:

  • Treatment of infectious and inflammatory diseases caused by susceptible pathogens:
  • Upper respiratory tract and ENT infections (otitis media, sinusitis, tonsillitis).
  • Lower respiratory tract infections (acute and chronic bronchitis, pneumonia, lung abscess, pleural empyema).
  • Urinary tract and pelvic infections (pyelonephritis, cystitis, urethritis, prostatitis, endometritis, gonorrhea).
  • Skin and soft tissue infections (erysipelas, impetigo, abscesses, cellulitis, wound infections).
  • Bone and joint infections (osteomyelitis).
  • Surgical infection prophylaxis and post-operative wound infections.

Method of Administration and Dosage:

  • Administered orally.
  • To reduce potential gastrointestinal discomfort and optimize absorption, take Hibiotic N at the start of a meal.
  • Dosage is determined individually based on age, body weight, renal function, and severity of the infection.
  • Children aged 3 months and older (twice daily, every 12 hours):
    Body weight 8 kg: 3.0 mL.
    Body weight 12 kg: 4.5 mL.
    Body weight 16 kg: 6.0 mL.
    Body weight 20 kg: 7.5 mL.
    Body weight 24 kg: 9.0 mL.
    Body weight 28 kg: 10.5 mL.
    Body weight 32 kg: 12.0 mL.
    Body weight 36 kg: 13.5 mL.
  • Lower doses are used for mild skin/soft tissue infections and recurrent tonsillitis; higher doses are recommended for otitis media, sinusitis, lower respiratory, and bone/joint infections.
  • Treatment duration: Minimum course is 5 days.
  • Treatment should not exceed 14 days without clinical re-evaluation.

Contraindications:

  • Known hypersensitivity or allergic reaction to amoxicillin, clavulanic acid, penicillins, cephalosporins, or other beta-lactam antibiotics.
  • Infectious mononucleosis (high risk of developing a maculopapular rash).
  • Phenylketonuria.
  • History of amoxicillin/clavulanic acid-associated jaundice or hepatic dysfunction.
  • Severe renal impairment (creatinine clearance less than 30 mL/min).

Precautions:

  • Use with caution in patients with severe hepatic impairment, chronic renal failure, or gastrointestinal disease (including antibiotic-associated colitis history).
  • Perform periodic monitoring of hepatic, renal, and hematopoietic functions during prolonged therapy.
  • Cross-reactivity may occur in patients with known hypersensitivity to penicillins or cephalosporins.
  • Discontinue treatment immediately if an allergic reaction occurs.
  • May cause false-positive results in urine glucose tests (enzymatic glucose oxidase methods are recommended).

Adverse Reactions / Side Effects:

  • Gastrointestinal System: Common: nausea, vomiting, diarrhea; Rare: stomatitis, gastritis, elevated liver enzymes; Very rare: cholestatic jaundice, hepatitis, pseudomembranous colitis, tooth discoloration.
  • Allergic Reactions: Urticaria, skin rash, itching; Rare: angioedema, anaphylaxis, erythema multiforme, Stevens-Johnson syndrome.
  • Hematopoietic System: Reversible leukopenia, thrombocytopenia, hemolytic anemia, prolonged bleeding time.
  • Nervous System: Dizziness, headache, hyperactivity, anxiety, seizures (with high doses or renal impairment).
  • General: Fungal overgrowth (candidiasis/thrush), crystalluria, interstitial nephritis.

Pregnancy and Lactation:

Use during pregnancy and breastfeeding should be avoided unless clearly necessary and prescribed by a physician, evaluating potential maternal benefit against fetal/infant risk.

Storage Conditions:

  • Dry Powder:
    Store at a temperature not exceeding 25 °C in a dry place protected from light.
  • Reconstituted Suspension: 
    Store in a refrigerator (at 2–8 °C) and use within 7 days.
  • Do not freeze. 
  • Keep out of reach of children.

Packaging:

Cardboard box containing a bottle with 53.4 g of powder to prepare 80 mL of oral suspension, a measuring spoon/syringe, and a patient information leaflet.

Active Ingredients:

No comments yet. Be the first to write one.

Leave a Comment

Your comment will be published after moderation.
You’ll receive a notification to your email when someone replies.

← Check the "I'm not a robot" box